Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_assertion type Assertion NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_head.
- NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_assertion description "[C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_provenance.
- NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_assertion evidence source_evidence_literature NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_provenance.
- NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_assertion SIO_000772 21245420 NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_provenance.
- NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_assertion wasDerivedFrom befree-2016 NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_provenance.
- NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_assertion wasGeneratedBy ECO_0000203 NP866170.RAqoSCnjOnVKFUnIMk5Mhey_2pD_sjrsz2uHi8vtPdXew130_provenance.